JAMA Network cover image

JAMA Ophthalmology : Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

JAMA Network

00:00

Exploring mTOR Inhibitors in Retinal Diseases

This chapter examines the role and popularity of mTOR inhibitors in treating conditions like cancers and transplant rejections, with an eye towards their potential benefits for proliferative vitreoretinopathy (PVR). The discussion includes the motivations for their use, ongoing research efforts, and the advantages of using these drugs in surgical contexts.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app